David E. Goldgar

25.2k total citations · 1 hit paper
72 papers, 4.9k citations indexed

About

David E. Goldgar is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, David E. Goldgar has authored 72 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Genetics, 27 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in David E. Goldgar's work include BRCA gene mutations in cancer (48 papers), DNA Repair Mechanisms (17 papers) and Genomic variations and chromosomal abnormalities (16 papers). David E. Goldgar is often cited by papers focused on BRCA gene mutations in cancer (48 papers), DNA Repair Mechanisms (17 papers) and Genomic variations and chromosomal abnormalities (16 papers). David E. Goldgar collaborates with scholars based in France, United States and United Kingdom. David E. Goldgar's co-authors include Douglas F. Easton, Rosalind A. Eeles, Fergus J. Couch, Antonis C. Antoniou, Sean V. Tavtigian, Georgia Chenevix‐Trench, Katherine L. Nathanson, William D. Foulkes, Melissa C. Southey and Deborah J. Thompson and has published in prestigious journals such as New England Journal of Medicine, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

David E. Goldgar

72 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

2015 579 citations Douglas F. Easton, Paul D.P. Pharoah et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Goldgar France	37	3.2k	2.1k	1.1k	1.1k	820	72	4.9k
B. A. J. Ponder United Kingdom	30	1.4k 0.4×	1.6k 0.7×	994 0.9×	733 0.7×	775 0.9×	54	3.7k
Pierre O. Chappuis Switzerland	31	1.4k 0.4×	1.3k 0.6×	1.7k 1.5×	1.5k 1.3×	702 0.9×	107	3.6k
Shirley V. Hodgson United Kingdom	29	1.2k 0.4×	1.7k 0.8×	1.2k 1.0×	1.2k 1.1×	1.6k 1.9×	59	3.9k
Evgeny N. Imyanitov Russia	31	1.1k 0.3×	2.2k 1.0×	1.4k 1.3×	1.2k 1.1×	657 0.8×	278	4.1k
Nicoletta Biglia Italy	41	1.3k 0.4×	1.4k 0.6×	1.6k 1.4×	1.3k 1.2×	766 0.9×	195	5.0k
Hilmi Özçelik Canada	34	1.1k 0.3×	2.3k 1.1×	1.2k 1.0×	758 0.7×	636 0.8×	79	3.6k
Siqun L. Zheng United States	36	1.2k 0.4×	1.4k 0.7×	416 0.4×	724 0.7×	324 0.4×	79	3.9k
Jun‐ichi Akahira Japan	37	962 0.3×	1.4k 0.6×	841 0.7×	756 0.7×	186 0.2×	108	3.6k
Marja T. Nevalainen United States	37	728 0.2×	1.8k 0.8×	1.7k 1.5×	876 0.8×	257 0.3×	77	3.7k
Jórunn E. Eyfjörd Iceland	30	1.7k 0.5×	2.0k 0.9×	1.4k 1.3×	1.3k 1.1×	600 0.7×	64	3.8k

Countries citing papers authored by David E. Goldgar

Since Specialization

Citations

This map shows the geographic impact of David E. Goldgar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Goldgar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Goldgar more than expected).

Fields of papers citing papers by David E. Goldgar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Goldgar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Goldgar. The network helps show where David E. Goldgar may publish in the future.

Co-authorship network of co-authors of David E. Goldgar

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Goldgar. A scholar is included among the top collaborators of David E. Goldgar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Goldgar. David E. Goldgar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Easton, Douglas F., Paul D.P. Pharoah, Antonis C. Antoniou, et al.. (2015). Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk. New England Journal of Medicine. 372(23). 2243–2257. 579 indexed citations breakdown →

Guidugli, Lucia, V. Shane Pankratz, Namit Singh, et al.. (2012). A Classification Model for BRCA2 DNA Binding Domain Missense Variants Based on Homology-Directed Repair Activity. Cancer Research. 73(1). 265–275. 89 indexed citations

Lapointe, Julie, Belkacem Abdous, Stéphanie Camden, et al.. (2011). Influence of the family cluster effect on psychosocial variables in families undergoing BRCA1/2 genetic testing for cancer susceptibility. Psycho-Oncology. 21(5). 515–523. 5 indexed citations

Kote‐Jarai, Zsofia, Daniel Leongamornlert, Edward J. Saunders, et al.. (2011). BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. British Journal of Cancer. 105(8). 1230–1234. 256 indexed citations

Park, Daniel J., Fabrice Odefrey, Fleur Hammet, et al.. (2011). FAN1 variants identified in multiple-case early-onset breast cancer families via exome sequencing: no evidence for association with risk for breast cancer. Breast Cancer Research and Treatment. 130(3). 1043–1049. 12 indexed citations

Jalbout, Majida, Meriem Khyatti, Meriem Abdoun, et al.. (2011). XRCC1 and hOGG1 genes and risk of nasopharyngeal carcinoma in North African countries. Molecular Carcinogenesis. 50(9). 732–737. 33 indexed citations

Carvalho, Marcelo A., Sylvia M. Marsillac, Rachel Karchin, et al.. (2007). Determination of Cancer Risk Associated with Germ Line BRCA1 Missense Variants by Functional Analysis. Cancer Research. 67(4). 1494–1501. 95 indexed citations

Samson, C., Paul Bessette, Jocelyne Chiquette, et al.. (2006). No Evidence of BRCA1/2 Genomic Rearrangements in High-Risk French-Canadian Breast/Ovarian Cancer Families. PubMed. 10(2). 104–115. 41 indexed citations

Saxena, Sunita, Mishi Kaushal, R. S. Mohil, et al.. (2006). Contribution of germline BRCA1 and BRCA2sequence alterations to breast cancer in Northern India. BMC Medical Genetics. 7(1). 75–75. 77 indexed citations

10.

Wu, Kangjian, Shannon R. Hinson, Akihiro Ohashi, et al.. (2005). Functional Evaluation and Cancer Risk Assessment of BRCA2 Unclassified Variants. Cancer Research. 65(2). 417–426. 94 indexed citations

11.

Hughes, David J., Isabelle Coupier, Laure Barjhoux, et al.. (2004). Analysis of breast cancer risk modifying candidate genes in BRCA1 and BRCA2 mutation carriers. Cancer Research. 64. 301–301. 2 indexed citations

12.

Szabo, Csilla I., Mieke Schutte, Annegien Broeks, et al.. (2004). Are ATM Mutations 7271T→G and IVS10-6T→G Really High-Risk Breast Cancer-Susceptibility Alleles?. Cancer Research. 64(3). 840–843. 43 indexed citations

13.

Szabo, Csilla I., Nicola M. Suter, Elaine A. Ostrander, et al.. (2002). BRCA1 andBRCA2 sequence variants in Chinese breast cancer families. Human Mutation. 20(6). 474–474. 34 indexed citations

14.

Saxena, Sunita, Csilla I. Szabo, Laure Barjhoux, et al.. (2002). BRCA1 and BRCA2 in Indian breast cancer patients. Human Mutation. 20(6). 473–474. 55 indexed citations

15.

Shugart, Yin Yao & David E. Goldgar. (1999). Multipoint genomic scanning for quantitative loci: effects of map density, sibship size and computational approach. European Journal of Human Genetics. 7(2). 103–109. 5 indexed citations

16.

Jefferies, Sarah, Rosalind A. Eeles, David E. Goldgar, et al.. (1999). The role of genetic factors in predisposition to squamous cell cancer of the head and neck. British Journal of Cancer. 79(5-6). 865–867. 36 indexed citations

17.

Schuffenecker, Isabelle, Richard M. Brohet, David E. Goldgar, et al.. (1998). Risk and Penetrance of Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A Families with Mutations at Codon 634 of theRETProto-Oncogene¹. The Journal of Clinical Endocrinology & Metabolism. 83(2). 487–491. 88 indexed citations

18.

Bignell, Graham R., Federico Canzian, Markus Stark, et al.. (1997). Familial Nontoxic Multinodular Thyroid Goiter Locus Maps to Chromosome 14q but Does Not Account for Familial Nonmedullary Thyroid Cancer. The American Journal of Human Genetics. 61(5). 1123–1130. 160 indexed citations

19.

Struewing, Jeffery P., Susan L. Neuhausen, Lawrence C. Brody, et al.. (1996). The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nature Genetics. 14(2). 188–190. 298 indexed citations

20.

Goldgar, David E. & Pamela R. Fain. (1988). Models of multilocus recombination: nonrandomness in chiasma number and crossover positions.. PubMed. 43(1). 38–45. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact